Addressing unmet drug development needs.
Drug development is increasingly focused on precision medicine. One drug does not fit all, and a patient’s response to treatments varies throughout the population due to genomic and proteomic differences. Patients need to be selected carefully for clinical trials to increase the likelihood of success.
American Molecular Laboratories combines cutting-edge research with vast Biotechnology and Pharmaceutical research experience to improve clinical trial efficiency byidentifying biomarkersand developing assays that provide insights into tumor biology and a drug’s mechanism of action.
This enables American Molecular Laboratories to develop personalized tests for patients who may benefit from chemotherapy, targeted therapy or immunotherapy.
American Molecular Laboratories’ scientific team provides support beyond traditional service-based laboratories, offering of meaningful scientific strategies that deliver unique solutions in oncology, drug development and personalized medicine.